New FDA Policy On Diagnostics Studies “Fills A Big Gap,” CDRH Chief Says
This article was originally published in The Gray Sheet
Executive Summary
Companies specializing in diagnostic products should pay close attention to a new, statistics-focused guidance document from FDA, device center Director Dan Schultz says